Status:
RECRUITING
In Vivo Cross-Modal Imaging of Skin
Lead Sponsor:
Gabriel Sanchez
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Skin
Eligibility:
All Genders
2-90 years
Brief Summary
The overall objective of this study is to use VIO/FG-30350 ("VIO") to observe microscopic skin structure in people of different skin health at different anatomic locations and correlate microscopic fe...
Detailed Description
The overall objective of this study is to use VIO/FG-30350 ("VIO") to observe microscopic skin structure in people of different skin health at different anatomic locations and correlate microscopic fe...
Eligibility Criteria
Inclusion
- Participants, ages 2 - 90 years old
- Participant, or guardian, if applicable, must be willing to provide written informed consent prior to enrollment and agree to comply with protocol requirements. If applicable, child must be willing to provide written assent prior to enrollment and agree to comply with protocol requirements.
- Participant or guardian, if applicable, must have sufficient mental capacity to understand the Informed Consent and provide clinically relevant and reliable feedback regarding their experience with the device.
- Participant and guardian, if applicable, must comply with the protocol requirements.
- Participant or guardian, if applicable, must agree that anonymized personal data will be made available to Study Sponsor and requisite regional and international regulatory bodies
Exclusion
- Any general health condition or systemic disease that may represent, in the opinion of the Principal Investigator, a potential increased risk associated with device use
- Currently infected with a communicable skin infection (e.g., shingles or methicillin-resistant S. aureus), which does not include local and minimally pathogenic or non-pathogenic infections distant from the imaging location(s) (e.g., warts, acne)
- Any known allergies to any materials used in the preparation of skin and/or device use
- Has a temporary or permanent electrical implanted medical device
- \-
Key Trial Info
Start Date :
September 2 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT07188948
Start Date
September 2 2025
End Date
September 30 2025
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Enspectra Health
Mountain View, California, United States, 94040